Related Experiment Video
Updated: Jun 17, 2026
09:03
Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies
Published on: June 30, 2023
Metformin inhibits inflammatory angiogenesis in a murine sponge model
D O Xavier1, L S Amaral, M A Gomes
1FUMEC University, Physiology, Rua da Paisagem 240, Bairro Vila da Serra, Nova Lima, Minas Gerais, Brazil.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|January 8, 2010
Summary
Metformin treatment reduced key aspects of inflammatory angiogenesis, including vascularization and macrophage accumulation in mouse implants. This study reveals metformin
Area of Science:
- Pharmacology
- Immunology
- Biomedical Engineering
Background:
- Inflammatory angiogenesis is a complex process involving vascular growth and immune cell infiltration.
- Understanding the modulation of these processes is crucial for developing therapeutic strategies.
Purpose of the Study:
- To investigate the effects of metformin on angiogenesis, inflammatory cell accumulation, and cytokine production in a mouse sponge implant model.
- To explore the therapeutic potential of metformin in modulating inflammatory angiogenesis.
Main Methods:
- Polyester-polyurethane sponges were implanted in Swiss mice.
- Metformin (40 or 400mg/kg/day) was administered orally for six days.
- Implants were analyzed for hemoglobin, myeloperoxidase, N-acetylglucosaminidase, collagen, and cytokine levels.
Main Results:
- Metformin treatment significantly attenuated fibrovascular tissue components, including wet weight and vascularization (hemoglobin content).
- Macrophage recruitment (N-acetylglucosaminidase activity) and collagen deposition were reduced by metformin.
- Levels of transforming growth factor-beta1 (TGF-beta1) within the implants were decreased.
Conclusions:
- Metformin demonstrated a regulatory function on multiple parameters of inflammatory angiogenesis.
- These findings provide insight into the therapeutic mechanisms underlying metformin's actions in inflammatory conditions.
